Mid-Ohio Oncology/Hematology — Columbus, Ohio

Mid-Ohio Oncology/Hematology is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid-Ohio Oncology/Hematology has participated in 32 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma.

Sponsors: Celgene, Pharmacyclics LLC., Daiichi Sankyo.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Columbus

Browse all research sites in Ohio · View every site in Columbus

• Ohio State University Wexner Medical Center - Outpatient Care East
• Division of Radiation Oncology, The Ohio State University Wexner
• Mount Caramel East Hospital
• The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion
• The Wright Center of Innovation- The Ohio State University
• Ohio State University Wexner Medical Center: Division of Nephrology
• The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute
• The University of Ohio
• University Hospital East Ohio State University Medical Center
• Division of Cardiology - The Ohio State University Medical Center
• Ohio State University Med Ctr; MS Center
• Ohio State University, Ohio State University Medical Center The Richard M Ross Heart Hospital

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Ohio Oncology/Hematology?

Mid-Ohio Oncology/Hematology has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Ohio Oncology/Hematology conducted?

Mid-Ohio Oncology/Hematology has 32 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma.

Is Mid-Ohio Oncology/Hematology accredited by Crixeo Clinical Trials?

Mid-Ohio Oncology/Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Ohio Oncology/Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.